Kamke Trent G 4

What Happened

• Trent G. Kamke, Senior Vice President, Operations at Lemaitre Vascular (LMAT), was credited with seven small dividend‑equivalent rights on March 26, 2026. The entries total 10.06 shares (individual amounts: 0.694, 0.694, 1.187, 1.423, 1.592, 1.803, 2.667). Each was recorded at $0.00 because these are dividend‑equivalent rights paid in shares (derivative/compensation), not open‑market purchases or sales.

Key Details

• Transaction date: 2026-03-26; reported on Form 4 filed 2026-03-30 (transactions recorded at $0.00 per share).
• Total shares received: 10.06 dividend-equivalent shares (accrued and paid as part of prior equity awards).
• Shares owned after transaction: not reported in the supplied excerpt of the filing.
• Footnotes: These entries are dividend equivalent rights that accrued and vest proportionately with prior awards:
  • F1–F2: from RSU/PSU grants on 12/12/2022
  • F3–F4: from RSU/PSU grants on 12/08/2023
  • F5–F6: from RSU/PSU grants on 12/06/2024
  • F7: from an RSU grant on 12/10/2025
• Filing timeliness: Form shows filing date 2026-03-30 for transactions on 2026-03-26 (filed four days after the transactions); check the full Form 4 for any timeliness flag.

Context

• These are dividend‑equivalent payments tied to previously granted restricted stock units (RSUs) and performance share units (PSUs). They represent compensation paid in the economic equivalent of shares as the underlying awards vest, not a market purchase or sale.
• Such awards are routine compensation events and do not necessarily indicate a personal buy/sell decision by the insider.